Get the Latest Investment Ideas Delivered Straight to Your Inbox.

News Update

TICKERS: HSI; HSCHF

Healthcare Tech Company Receives US Patent
News Update

Source:

The U.S Patent and Trademark Office has granted the allowance to a technology company whose platform allows healthcare organizations to buy, sell and trade equipment and supplies.

H-Source Holdings Ltd. (HSI:TSX.V; HSCHF:OTCQB) recently announced it has received allowance by the U.S Patent and Trademark Office (USPTO) for U.S. Patent Application No. 12/772,019.

"We are pleased the USPTO has allowed our patent, "Perishable medical product management systems, perishable medical product management methods, and perishable medical product resale methods." Intellectual property (IP) has been a focus for us from the beginning. Combined with our granted patent in Japan and additional pending applications, we are committed to growing our IP portfolio. Our current allowed and granted patents not only support our existing platform but will also provide us new opportunities to innovate and offer breakthrough healthcare solutions," explained Murray Walden, president of H-Source.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry with offices in Seattle and Spokane, Wash.

Want to read more Life Sciences Report articles/interviews like this? Sign up for our free e-newsletter, and you'll learn when new articles have been published. To see recent articles and interviews with industry analysts and commentators, visit our Streetwise Interviews page.

Disclosure:
1) Jake Richardson compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: H-Source Holdings. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of H-Source Holdings, a company mentioned in this article.




321 Gold

Want to read more about Life Sciences Tools & Diagnostics and Technology investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe